[Clinical importance of determining the activity of an acid-stable proteinase inhibitor in the urine of arterial hypertension patients].
The determination of urine acid-stable proteinase inhibitor activity proved to be more informative at the early stages of renal tissue lesions, as compared to measurement of intermediate molecule blood level. It can be used as a diagnostic test in patients with parenchymatous renal diseases accompanied by blood pressure elevation, and essential hypertension.
D000293:Adolescent; D000328:Adult; D002908:Chronic Disease; D004355:Drug Stability; D005260:Female; D005921:Glomerulonephritis / Q000175:diagnosis; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000175:diagnosis / Q000652:urine*; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood; D011480:Protease Inhibitors / Q000652:urine*; D011704:Pyelonephritis / Q000175:diagnosis; D014118:Toxins, Biological / Q000097:blood
D010455:Peptides; D011480:Protease Inhibitors; D014118:Toxins, Biological; C026865:uremia middle molecule toxins
Klinicheskoe znachenie opredeleniia aktivnosti kislotostabil'nogo ingibitora proteinaz v moche bol'nykh arterial'nymi gipertoniiami.